NCT00332072View on ClinicalTrials.gov

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

541

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Ocular Hypertension
Interventions
DRUG

bimatoprost/timolol fixed combination

Trial Locations (1)

Unknown

Ogden

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00332072 - Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter